|
Nipocalimab Clinical Trials
4 actively recruiting trials across 4 locations
No change since May 2026
Also known as: JNJ-80202135, JNJ-80202135, JNJ-86507083, M281, JNJ-80202135, M281, JNJ-86507083, M281/JNJ-80202135
Pipeline
Phase 3: 3Phase 2/3: 1
Top Sponsors
- Janssen Research & Development, LLC4
Paradise Valley, Arizona1 trial
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Neuromuscular Research Center and Clinic
Phase 3
Phoenix, Arizona1 trial
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Phoenix Children's Hospital
Phase 2/3
Beverly Hills, California1 trial
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
David S Hallegua MD A Professional Corporation
Phase 3
Pomona, California1 trial
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
The Neurology Group
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.